Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HASSAN KANJ

NPI
1598815987
CMS profile
1298671
Location
PISCATAWAY, NJ

General Payments · PY2018–2024

$175,733.19

  • Reported across 1,380 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,088.33

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $1,788.03 4
NOVARTIS PHARMACEUTICALS CORPORATION $151.74 2
Abbott Laboratories $60.82 4
SANOFI-AVENTIS U.S. LLC $35.47 2
DEXCOM, INC. $20.91 1
Kyowa Kirin, Inc. $16.44 1
Medtronic, Inc. $14.92 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $66,980.55 315
PY2019 $41,730.19 265
PY2020 $25,911.53 199
PY2021 $8,237.74 165
PY2022 $20,833.92 278
PY2023 $9,950.93 143
PY2024 $2,088.33 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $14.99 01/10/2024 Food and Beverage Undisputed 01/23/2026 1125374006 CMS
Abbott Laboratories $14.99 01/10/2024 Food and Beverage Undisputed 01/23/2026 1125374010 CMS
Abbott Laboratories $15.34 02/08/2024 Food and Beverage Undisputed 01/23/2026 1125374015 CMS
Abbott Laboratories $15.50 04/02/2024 Food and Beverage Undisputed 01/23/2026 1125374019 CMS
Dexcom, Inc. $20.91 03/18/2024 Food and Beverage Undisputed 01/23/2026 1153303249 CMS
Kyowa Kirin, Inc. $16.44 02/21/2024 Food and Beverage Undisputed 01/23/2026 1127031093 CMS
Medtronic, Inc. $14.92 01/30/2024 Food and Beverage Undisputed 01/23/2026 1116874309 CMS
Novartis Pharmaceuticals Corporation $16.38 01/23/2024 Food and Beverage Undisputed 01/23/2026 1087053456 CMS
Novartis Pharmaceuticals Corporation $135.36 02/28/2024 Food and Beverage Undisputed 01/23/2026 1087053466 CMS
Novo Nordisk Inc $10.83 02/08/2024 Food and Beverage Undisputed 01/23/2026 1108578027 CMS
Novo Nordisk Inc $6.22 02/22/2024 Food and Beverage Undisputed 01/23/2026 1108578203 CMS
Novo Nordisk Inc $1,754.50 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1108575884 CMS
Novo Nordisk Inc $16.48 04/22/2024 Food and Beverage Undisputed 01/23/2026 1108576042 CMS
SANOFI-AVENTIS U.S. LLC $16.18 01/16/2024 Food and Beverage Undisputed 01/23/2026 1139630085 CMS
SANOFI-AVENTIS U.S. LLC $19.29 02/28/2024 Food and Beverage Undisputed 01/23/2026 1139630087 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.